Alpha 1 Global

Our mission is to develop a collaborative global network of Alpha-1 patient leaders, physicians, and researchers, to increase awareness, detection, and access to care for Alphas around the world.


Alpha-1 Global Reveals 2020 Global Hub Centers

Alpha-1 Global is proud to announce that three Alpha-1 patient organisations have been selected as Alpha-1 Global Hub Centers. The Alpha-1 Foundation Ireland, Fundación Argentina …

Read More

Grifols’s Prolastina Approved for Use in Denmark

The Alpha-1 Foundation is proud to report that multinational pharmaceutical manufacturer Grifols has received approval for reimbursement by the Danish Medicines Council for Prolastina, a …

Read More

Danish Medicines Council Grants Approval for CSL Behring’s Respreeza as Standard Treatment for Severe Alpha-1 Antitrypsin Deficiency Patients

HATTERSHEIM AM MAIN, Germany, Jan. 24, 2020 – Global biopharmaceutical company CSL Behring announced that the Danish Medicines Council has published its final decision regarding …

Read More

European Lung Foundation Conducts Alpha-1 Survey to Establish Future Research Priorities

The European Lung Foundation (ELF) is asking members of the Alpha-1 community for their help in identifying the challenges of care, treatment and living with …

Read More

Alpha-1 Global Announces Launch of Alpha-1 Global Hub Centers

Alpha-1 Global is launching a program called the Alpha-1 Global Hub Centers. The goal of the program is to create 5-6 centers globally that will …

Read More

CSL Behring Announces Grant for EU Advocacy Development

Dear EU Alpha-1 Global Partners: We are pleased to provide you information regarding CSL Behring’s announcement for Local Empowerment for Advocacy Development (LEAD) Grants available …

Read More

CSL Behring announcement on their product Zemaira

Today, the Alpha-1 Foundation received the following communication from CSL Behring, regarding Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin …

Read More

Alpha-1 Global mourns the loss of Guillermo Menga, MD

It is with a heavy heart that the Alpha-1 Global program, at the Alpha-1 Foundation, announces the passing of Guillermo Menga, MD, director of the …

Read More

Karen, living with Alpha-1 Antitrypsin Deficiency (Alpha-1)

I am Karen, and I am 46 years old and an elite disabled athlete. Because of my plasma therapy, I can participate in sports, run …

Read More

4th International Research Conference on Alpha-1 Antitrypsin & 7th Alpha-1 Global Patient Congress

The Alpha-1 Foundation hosted the 4th International Research Conference and the 7th Global Patient Congress, April 3-6, 2019, in Dubrovnik, Croatia. The Patient Congress was …

Read More

Alpha-1 Around The Globe

Click on the country flags below to learn more about country specific contact and general information, access to care, and available resources

Join Our Newsletter

Subscribe to stay in touch with the latest in Alpha-1 Global